Patents Assigned to Blasticon Biotechnologische Forschung GmbH
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Patent number: 7553663
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: June 30, 2009
    Assignee: Blasticon Biotechnologische Forschung GmbH
    Inventors: Bernd Karl Friedrich Kremer, Fred Fändrich, Maren née Schulze Ruhnke
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Patent number: 7553660
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Grant
    Filed: May 26, 2005
    Date of Patent: June 30, 2009
    Assignee: Blasticon Biotechnologische Forschung GmbH
    Inventors: Bernd Karl Friedrich Kremer, Fred Fändrich, Maren Ruhnke (née Schulze)
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Patent number: 7517686
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Grant
    Filed: November 21, 2005
    Date of Patent: April 14, 2009
    Assignee: Blasticon Biotechnologische Forschung GmbH
    Inventors: Bernd Karl Friedrich Kremer, Fred Fändrich, Maren née Schulze Ruhnke
  • Transplant acceptance inducing cells of monocytic origin and their preparation and use
    Publication number: 20060286670
    Abstract: The invention relates to transplant acceptance inducing cells of monocytic origin, their production as well as their use for generating transplant acceptance. The invention also relates to the monoclonal antibody GM-7, which specifically recognises human transplant acceptance inducing cells of the invention. The invention further relates to the use of the antibody GM-7 for detection and/or selection transplant-acceptance inducing cells.
    Type: Application
    Filed: July 11, 2003
    Publication date: December 21, 2006
    Applicant: BLASTICON BIOTECHNOLOGISCHE FORSCHUNG GMBH
    Inventors: Bernd Kremer, Fred Fandrich, Maren Schulze
  • Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
    Patent number: 7138275
    Abstract: The invention relates to the production of adult dedifferentiated, programmable stem cells from human monocytes by cultivation of monocytes in a culture medium which contains M-CSF and IL-3. The invention further relates to pharmaceutical preparations, which contain the dedifferentiated, programmable stem cells and the use of these stem cells for the production of target cells and target tissue.
    Type: Grant
    Filed: March 28, 2003
    Date of Patent: November 21, 2006
    Assignee: Blasticon Biotechnologische Forschung GmbH
    Inventors: Bernd Karl Friedrich Kremer, Fred Fändrich, Maren née Schulze Ruhnke